---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-058213"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T00:59:59.095847+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q3 revenue $65.3M (+14% YoY); net loss widens to $248.7M on non-cash charges

## Summary
- Revenue $65.3M, up 14% YoY from $57.4M; above high-end of guidance.
- Net loss $248.7M (381% of revenue) vs $6.9M loss in Q3 2022; adjusted net income $14.6M.
- Adjusted EBITDA $21.7M (33% of revenue) vs $16.4M (29%) a year ago.
- Q4 guidance: revenue $65.5M-$66.5M, adjusted EPS $0.06-$0.08 on 155.6M diluted shares.
- Enterprise customers grew 10% YoY to 555; customer win-backs and expansions noted.

## SEC filing metadata
- accession: 0000950170-23-058213
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/0000950170-23-058213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/dh-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-058213
- JSON: https://secwatch.observer/filing/0000950170-23-058213.json
- Plain text: https://secwatch.observer/filing/0000950170-23-058213.txt

## Key facts
- Earnings Releases
  Definitive Healthcare Corp. reported the quarter ended September 30, 2023 results: revenue $65.3 million, net income $(248.7) million.
  - Period: the quarter ended September 30, 2023
  - Revenue: $65.3 million
  - Net income: $(248.7) million
  - Result: reported results
  source text: EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023 Third quarter revenue grew 14% year-over-year to $65.3 million Framingham, MA (November 2, 2023) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/0000950170-23-058213-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.